( NASDAQ-NMS:AMRI )

News from AMRI A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Feb 21, 2017, 08:05 ET AMRI Announces Agreement with Accord Healthcare to Jointly Develop, Manufacture and Commercialize Parenteral Drug Products

AMRI (NASDAQ: AMRI) today announced that it has entered into an agreement with the pharmaceutical group Ferrer and Accord Healthcare, Inc....


Feb 21, 2017, 07:28 ET AMRI Announces Fourth Quarter and Full Year 2016 Results and Provides 2017 Outlook

AMRI (NASDAQ: AMRI) today reported financial and operating results for the fourth quarter and full year ended December 31, 2016 and provided an...


Feb 15, 2017, 08:00 ET AMRI Schedules Fourth Quarter and Full Year 2016 Earnings Release and Conference Call

AMRI (NASDAQ: AMRI) today announced it will issue fourth quarter and full year 2016 financial results before the opening of the market on Tuesday,...


Feb 07, 2017, 08:00 ET AMRI Announces Strategic Alliance to Advance Mass Spectrometry Capabilities for Drug Discovery

AMRI (NASDAQ: AMRI), a global contract research and manufacturing organization working to improve patient outcomes and quality of life, has entered...


Dec 13, 2016, 08:00 ET AMRI CEO to Present at 35th Annual J.P. Morgan Healthcare Conference

Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at...


Nov 29, 2016, 07:45 ET AMRI Announces API Supply Agreement with Shire

AMRI (NASDAQ: AMRI) announced today that it has entered into a multi-year supply agreement for an undisclosed product with Shire US Manufacturing,...


Nov 14, 2016, 07:45 ET AMRI to Present Two Posters at AAPS 2016

AMRI (NASDAQ: AMRI), a premier contract services provider to the life sciences industry, will be presenting two posters at the 2016 AAPS Annual...


Nov 08, 2016, 07:30 ET AMRI Announces Third Quarter 2016 Results

AMRI (NASDAQ: AMRI) today reported financial and operating results for the third quarter ended September 30, 2016 and reiterated its outlook for...


Oct 20, 2016, 08:00 ET AMRI Schedules Third Quarter 2016 Earnings Release and Conference Call

AMRI (NASDAQ: AMRI) today announced it will issue third quarter 2016 financial results before the opening of the market on Tuesday, November 8,...


Oct 03, 2016, 09:27 ET AMRI to Unveil Powerful Portfolio of APIs and Capabilities at CPhI in Barcelona

 AMRI (NASDAQ: AMRI), a premier contract services provider to the life sciences industry, will be showcasing its comprehensive portfolio...


Aug 30, 2016, 08:00 ET AMRI CEO to Present at Morgan Stanley Global Healthcare Conference

Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at...


Aug 24, 2016, 08:00 ET AMRI CEO to Present at Baird 2016 Global Healthcare Conference

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will...


Aug 23, 2016, 16:05 ET AMRI Licenses CRISPR-Cas9 Gene Editing Technology

 AMRI (NASDAQ: AMRI) today announced that it entered into a non-exclusive commercial license agreement with the Broad Institute of MIT and...


Aug 04, 2016, 07:30 ET AMRI Announces Second Quarter 2016 Results

 AMRI (NASDAQ: AMRI) today reported financial and operating results for the second quarter ended June 30, 2016 and provided an update to its...


Jul 15, 2016, 08:00 ET AMRI to Announce Second Quarter 2016 Results

AMRI (NASDAQ: AMRI) today announced it will issue second quarter 2016 financial results before the opening of the market on Thursday, August 4,...


Jul 11, 2016, 07:25 ET AMRI Completes Acquisition of Euticals

 AMRI (NASDAQ: AMRI) today announced that it has completed the acquisition of Prime European Therapeuticals S.p.A., also known as "Euticals", a...


Jun 22, 2016, 08:00 ET Teewinot Life Sciences Corporation Licenses Biosynthetic Technology to AMRI for the Production and Sale of the First Commercially Available CBCA Analytical Standard

 Teewinot Life Sciences Corporation (Teewinot) and Albany Molecular Research, Inc. (NASDAQ: AMRI) today announced that AMRI has licensed...


Jun 14, 2016, 08:05 ET AMRI Selected as a Dedicated Chemical Biology Consortium Center to Expand Drug Development

 AMRI (NASDAQ: AMRI) today announced that its Buffalo, N.Y. site has been selected to participate as a Dedicated Chemical Biology...


May 23, 2016, 08:00 ET AMRI CEO to Present at Jefferies 2016 Healthcare Conference

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will...


May 10, 2016, 10:28 ET AMRI Clarifies 2016 Revenue Guidance

AMRI (NASDAQ: AMRI) clarified its 2016 revenue guidance, following the company's first quarter earnings conference call held earlier this...


May 10, 2016, 07:35 ET AMRI Announces First Quarter 2016 Results

 AMRI (NASDAQ: AMRI) today reported financial and operating results for the first quarter ended March 31, 2016 and provided an update to its...


May 09, 2016, 08:00 ET AMRI Appoints Louis Yu, Ph.D., as Senior Vice President, Quality and Compliance

AMRI (NASDAQ: AMRI) today announced that it has hired Louis Yu, Ph.D., to fill the newly created position of senior vice president of quality and...


May 05, 2016, 07:33 ET AMRI to Acquire Euticals in a Strategic Transaction That Expands its API Development and Manufacturing Business

- Enters definitive agreement to acquire Euticals for $358 million in stock, cash and a seller note - Positions AMRI as one of the...


Apr 28, 2016, 07:00 ET AMRI to Announce First Quarter 2016 Results

 AMRI (NASDAQ: AMRI) today announced it will issue first quarter 2016 financial results before the opening of the market on Tuesday, May 10,...


Mar 14, 2016, 08:00 ET AMRI Wins Four Life Science Leader Awards

 AMRI (NASDAQ: AMRI) today announced that it has been recognized as a Life Science Leader CMO Leadership Award recipient in the categories of...